Digg StumbleUpon LinkedIn YouTube Flickr Facebook Twitter RSS Reset
Comments Off

GASTROINTESTINAL AND LIVER DISEASE – Exercise 21

By | Published: November 2, 2015

The multiple choice questions in this online test paper focuses on GASTROINTESTINAL AND LIVER DISEASE MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online GASTROINTESTINAL AND LIVER DISEASE MCQ Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 30 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. achillis tendinitis and rupture is associated with which of the following medicines

 
 
 
 

Q 2. drug used for postoperative prophylaxis of CD

 
 
 
 

Q 3. infusion reaction that occur with infliximab therapy is due to

 
 
 
 

Q 4. which side effect of glucocorticoid therapy in IBD is not related to dose & duration of therapy

 
 
 
 

Q 5. infliximab therapy is associated with

 
 
 
 

Q 6. infliximab is not useful in

 
 
 
 

Q 7. methotrexate potential toxicities include all

 
 
 
 

Q 8. not a side effect of cyclosporine therapy

 
 
 
 

Q 9. active end product of azathioprine

 
 
 
 

Q 10. treatment of choice in severe ulcerative colitis

 
 
 
 

Q 11. lipophilic peptide drug include

 
 
 
 

Q 12. tacrolimus mechanism of action is similar to

 
 
 
 

Q 13. methotrexate inhibits which of the following

 
 
 
 

Q 14. first line treatment in active inflammatory , fistlizing and perianal CD is

 
 
 
 

Q 15. adalimumab is a

 
 
 
 

Q 16. sizures may complicate cyclosporine therapy if there is

 
 
 
 

Q 17. infliximab therapy indication include all except

 
 
 
 

Q 18. anti-TNF monoclonal antibody useful in treatment of moderate to severely active CD in patient is

 
 
 
 

Q 19. natalizumab is

 
 
 
 

Q 20. first biologic thearapy approved for CD was

 
 
 
 

Q 21. following specifically blocks integrin α4 and prevents lymphocyte trafficking to the intestine in IBD

 
 
 
 

Q 22. following is considered to be useful additional therapy with treatment of CD with infliximab

 
 
 
 

Q 23. infliximab is

 
 
 
 

Q 24. cyclosporine acts by inhibition of

 
 
 
 

Q 25. severe UC patients refractory to treatment with iv glucocorticoids should be treated with

 
 
 
 

Q 26. regarding azathioprine use in IBD false statement include

 
 
 
 

Q 27. false regarding treatment of IBD

 
 
 
 

Q 28. natalizumab causes activation of which virus leadinfg to PML

 
 
 
 

Q 29. 5-ASA agents act within

 
 
 
 

Q 30. opportunistic infection that commonly occurs with cyclosporine therapy is

 
 
 
 


pgmedmin

Comments are closed.